Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04239040
Title GVAX Plus Checkpoint Blockade in Neuroblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

neuroblastoma

Therapies

GVAX + Ipilimumab + Nivolumab

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.